Post-acute care has always operated under tight margins and heavy regulation, but the pressure facilities are facing now is fundamentally different. Leaders are being asked to improve patient outcomes, maintain

The healthcare industry has spent billions on automation in the last decades, but for many, AI hasn’t delivered the efficiency or financial returns they expected. Recent research from MIT found

For those who have experienced a stroke, the chances of a second one are high. An experimental Bayer drug reduced this risk by 26% in a pivotal trial, supporting the

The Department of Health and Human Services is scrapping the 340B Drug Pricing Program‘s rebate model, according to a Thursday court filing. Hospitals are reacting with glee, as the rebate

Chamber Cardio, a value-based cardiology company, announced Wednesday that it raised $60 million in Series A funding, which will be used to help scale the startup. The company works with

EHR giant Epic rolled out an AI charting tool on Thursday, giving its customers a built-in tool that listens during appointments, drafts clinical documentation and prepares orders based on what

The Covid-19 pandemic spurred a rapid expansion of health tech companies, and new market realities post pandemic meant it was only a matter of time before some consolidated. Indeed, investors

Despite progress made in cancer immunotherapy, some patients don’t respond to these treatments or they stop responding after a period of time. Eikon Therapeutics’ lead drug candidate could address these

Hair loss remains an area lacking biotechnology innovation. The drugs currently available are older products offering limited efficacy. Some of them cannot be used by women. Veradermics aims to shake

People have been riding the GLP-1 wave to achieve quick and significant weight loss. But given the drug’s effect on controlling type 2 diabetes, it’s no surprise that DexCom CEO